Amendment to PA-04-157, Research on Malignancies in AIDS and Acquired Immune Suppression

Notice Number: NOT-CA-05-031

Key Dates
Release Date: October 20, 2005

Issued by
National Cancer Institute (NCI), (http://www.nci.nih.gov)

This Notice is to inform the scientific community that the NCI is amending Program Announcement PA-04-157 , Research on Malignancies in AIDS and Acquired Immune Suppression, as follows:

Dr. Mukesh Verma has replaced Dr. Sandra Melnick as the contact person for questions about molecular epidemiology studies as related to this funding opportunity (his contact information is presented below); and

Dr. Kishor Bhatia has replaced Dr. Jodi Black as a contact person for questions about pre-clinical diagnostics and therapeutics studies as related to this funding opportunity (his contact information is also presented below).

Inquiries

Direct questions about the indicated scientific/research issues to:

Mukesh Verma, Ph.D.
Acting Branch Chief
Analytic Epidemiology Research Branch
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
6130 Executive Blvd. , EPN Room 5104, MSC 7324
Bethesda, MD 20892-7324  (for U.S. Postal Service express or regular delivery)
Rockville, MD 20852 (for express/courier delivery)
Phone: (301) 594-7344
FAX: (301) 402-4279
E-mail: vermam@mail.nih.gov

Kishor Bhatia, Ph.D., MRCPath.
Director, Office of AIDS Malignancies Program
National Cancer Institute
6116 Executive Boulevard, Suite 505
Bethesda, MD 20892 (for U.S. Postal Service delivery)
Rockville, MD 20852 (for express/courier delivery)
Phone: (301) 496-4995
FAX: (301) 480-4137
E-mail: bhatiak@mail.nih.gov